RVL Pharmaceuticals plc Quarterly Return On Equity in % from Q3 2019 to Q2 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
RVL Pharmaceuticals plc quarterly/annual Return On Equity history and growth rate from Q3 2019 to Q2 2023.
  • RVL Pharmaceuticals plc Return On Equity for the quarter ending June 30, 2023 was -155 %, a 78.1% decline year-over-year.
  • RVL Pharmaceuticals plc annual Return On Equity for 2022 was -83.5 %, a 8.32% increase from 2021.
  • RVL Pharmaceuticals plc annual Return On Equity for 2021 was -91.1 %, a 48.5% decline from 2020.
  • RVL Pharmaceuticals plc annual Return On Equity for 2020 was -61.3 %, a 49.7% increase from 2019.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2023 -155 -68.1 -78.1% Apr 1, 2023 Jun 30, 2023
Q1 2023 -104 -11.3 -12.3% Jan 1, 2023 Mar 31, 2023
Q4 2022 -83.5 +7.58 +8.32% Oct 1, 2022 Dec 31, 2022
Q3 2022 -77.7 +54.7 +41.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 -87.1 +4.15 +4.55% Apr 1, 2022 Jun 30, 2022
Q1 2022 -92.2 -17.5 -23.3% Jan 1, 2022 Mar 31, 2022
Q4 2021 -91.1 -29.8 -48.5% Oct 1, 2021 Dec 31, 2021
Q3 2021 -132 -94.4 -248% Jul 1, 2021 Sep 30, 2021
Q2 2021 -91.3 +25.8 +22% Apr 1, 2021 Jun 30, 2021
Q1 2021 -74.8 +88.5 +54.2% Jan 1, 2021 Mar 31, 2021
Q4 2020 -61.3 +60.5 +49.7% Oct 1, 2020 Dec 31, 2020
Q3 2020 -38 +83.2 +68.6% Jul 1, 2020 Sep 30, 2020
Q2 2020 -117 Apr 1, 2020 Jun 30, 2020
Q1 2020 -163 Jan 1, 2020 Mar 31, 2020
Q4 2019 -122 Oct 1, 2019 Dec 31, 2019
Q3 2019 -121 Jul 1, 2019 Sep 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.